Literature DB >> 30092179

On the front lines of the opioid epidemic: Rescue by naloxone.

Phil Skolnick1.   

Abstract

Naloxone is a specific, high affinity opioid antagonist that has been used to treat suspected or confirmed overdose for more than 40 years. Naloxone use was initially confined to an emergency room setting, but the dramatic rise in opioid overdose events over the past two decades has, with increasing frequency, shifted naloxone use to first responders including police, emergency medical technicians, and the friends and family of overdose victims. The opioids responsible for overdose events have also evolved, from prescription opioids to heroin and most recently, very high potency synthetic opioids such as fentanyl. In 2016, synthetic opioids were linked to more overdose fatalities than either prescription opioids or heroin. In this review, I will discuss the evolution and use of naloxone products by first responders and the development of additional rescue medications in response to the unprecedented dangers posed by synthetic opioids.
Copyright © 2018 The Author. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Opioid overdose - naloxone – fentanyl – heroin – nalmefene - AMPAkines

Mesh:

Substances:

Year:  2018        PMID: 30092179     DOI: 10.1016/j.ejphar.2018.08.004

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.

Authors:  Philip Krieter; Shwe Gyaw; Roger Crystal; Phil Skolnick
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

2.  Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.

Authors:  Jarkko Johansson; Jussi Hirvonen; Zsófia Lovró; Laura Ekblad; Valtteri Kaasinen; Olli Rajasilta; Semi Helin; Jouni Tuisku; Saija Sirén; Mirka Pennanen; Arvind Agrawal; Roger Crystal; Petri J Vainio; Hannu Alho; Mika Scheinin
Journal:  Neuropsychopharmacology       Date:  2019-03-13       Impact factor: 7.853

3.  Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride.

Authors:  Ting Zhang; Meng Li; Xiaolu Han; Guangjun Nie; Aiping Zheng
Journal:  AAPS PharmSciTech       Date:  2022-05-16       Impact factor: 3.246

Review 4.  Reversal Agents in Sedation and Anesthesia Practice for Dentistry.

Authors:  Michelle Wong
Journal:  Anesth Prog       Date:  2022-04-01

Review 5.  Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.

Authors:  Randy Torralva; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

6.  Neural basis of opioid-induced respiratory depression and its rescue.

Authors:  Shijia Liu; Dong-Il Kim; Tae Gyu Oh; Gerald M Pao; Jong-Hyun Kim; Richard D Palmiter; Matthew R Banghart; Kuo-Fen Lee; Ronald M Evans; Sung Han
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 12.779

7.  Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.

Authors:  Philip Krieter; Shwe Gyaw; C Nora Chiang; Roger Crystal; Phil Skolnick
Journal:  J Clin Pharmacol       Date:  2019-01-30       Impact factor: 3.126

8.  One opioid user saving another: the first study of an opioid overdose-reversal and naloxone distribution program addressing hard-to-reach drug scenes in Denmark.

Authors:  Birgitte Thylstrup; Morten Hesse; Marian Jørgensen; Henrik Thiesen
Journal:  Harm Reduct J       Date:  2019-12-05

9.  Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City.

Authors:  Farah Riazi; Wilma Toribio; Emaun Irani; Terence M Hughes; Zina Huxley-Reicher; Elisa McBratney; Trang Vu; Keith Sigel; Jeffrey J Weiss
Journal:  Front Sociol       Date:  2021-07-07

Review 10.  Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review.

Authors:  Karim Chamie; Vishnukamal Golla; Andrew T Lenis; Patrick M Lec; Siamak Rahman; Eugene R Viscusi
Journal:  J Gastrointest Surg       Date:  2020-08-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.